Cheng, Zhixiang <br/><br/>
Inhibition of BET bromodomain targets genetically diverse glioblastoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2013 
 - 1748-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-3066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Azepines--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Disease Progression<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Knockdown Techniques<br/>Glioblastoma--drug therapy<br/>Humans<br/>Mice<br/>Protein Kinase Inhibitors--administration & dosage<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>RNA Interference<br/>Signal Transduction--drug effects<br/>Transcription, Genetic--drug effects<br/>Triazoles--administration & dosage<br/>Xenograft Model Antitumor Assays